NaPi-IIa相关疾病的临床异质性与表型扩展
研究对两名以色列和土耳其裔特发性婴儿高钙血症伴部分近端肾小管病患者及亲属行全外显子测序,发现两者均携带先前报道的NaPi-IIa纯合功能丧失插入重复突变(p.I154_V160dup),呈同一祖先血缘遗传;体外定位显示突变蛋白滞留内质网并被蛋白酶体降解。
要点
- 两名患儿均携带NaPi-IIa纯合插入重复突变p.I154_V160dup,呈同一祖先血缘遗传。
- 该突变先前由本团队在两名成人同胞中报道,表现为肾范可尼综合征、低磷性骨病和进行性肾衰竭。
- 体外实验显示p.I154_V160dup等转运缺陷突变体滞留于内质网,呈未成熟低糖基化状态,导致蛋白酶体提前降解。
核心结论
- 本研究扩展了NaPi-IIa功能缺陷的表型谱,强化其与近端肾小管损伤的联系,为纵向研究该病自然史提供条件,并揭示NaPi-IIa突变体功能丧失与转运障碍相关的细胞通路。
研究设计与样本
- 对两名临床表现为特发性婴儿高钙血症伴部分近端肾小管病、分别来自以色列和土耳其裔家庭的患儿及其近亲行全外显子测序,并对突变NaPi-IIa行体外定位和转运分析。
主要发现
- 两名患者的突变与单倍型分析均发现先前报道的NaPi-IIa纯合功能丧失插入重复突变(p.I154_V160dup),继承自共同祖先且为同一血缘遗传。
- 该共同突变最初由本团队在两名成人同胞中报道,其临床表现为肾范可尼综合征、低磷性骨病和进行性肾衰竭,且这两名成人是本文其中一名婴儿的家系成员。
- 体外定位试验和生化分析显示,p.I154_V160dup及其他携带转运缺陷的NaPi-IIa突变体异常滞留于内质网,呈未成熟和低糖基化状态,导致蛋白酶体提前降解。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: NaPi-IIa, encoded by SLC34A1, is a key phosphate transporter in the mammalian proximal tubule and plays a cardinal role in renal phosphate handling. NaPi-IIa impairment has been linked to various overlapping clinical syndromes, including hypophosphatemic nephrolithiasis with osteoporosis, renal Fanconi syndrome with chronic kidney disease, and, most recently, idiopathic infantile hypercalcemia and nephrocalcinosis. OBJECTIVES: We studied the molecular basis of idiopathic infantile hypercalcemia with partial proximal tubulopathy in two apparently unrelated patients of Israeli and Turkish descent. DESIGN: Genetic analysis in two affected children and their close relatives was performed using whole-exome sequencing, followed by in vitro localization and trafficking analysis of mutant NaPi-IIa. RESULTS: Mutation and haplotype analyses in both patients revealed a previously described homozygous loss-of-function inserted duplication (p.I154_V160dup) in NaPi-IIa, which is inherited identical-by-descent from a common ancestor. The shared mutation was originally reported by our team in two adult siblings with renal Fanconi syndrome, hypophosphatemic bone disease, and progressive renal failure who are family members of one of the infants reported herein. In vitro localization assays and biochemical analysis of p.I154_V160dup and of additional NaPi-IIa mutants harboring a trafficking defect indicate aberrant retention at the endoplasmic reticulum in an immature and underglycosylated state, leading to premature proteasomal degradation. CONCLUSIONS: Our findings expand the phenotypic spectrum of NaPi-IIa disruption, reinforce its link with proximal tubular impairment, enable longitudinal study of the natural history of the disease, and shed light on cellular pathways associated with loss of function and impaired trafficking of NaPi-IIa mutants.
引用
- Demir K, Yildiz M, Bahat H, et al. Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease. J Clin Endocrinol Metab. 2017. PMID: 29029121. doi:10.1210/jc.2017-01592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。